Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Blood
|
April 13, 2023
Location, location, location
Melinda A Biernacki
Blood Advances
|
February 13, 2026
The TCXpress lane to T-cell receptor-engineered T cells
Melinda A Biernacki
Blood Advances
|
February 24, 2026
The TCXpress lane to T-cell receptor-engineered T cells
Melinda A Biernacki
Transplantation and Cellular Therapy
|
November 1, 2025
Capturing the Big Picture of HY Antigens and Transplantation Outcomes
Melinda A Biernacki
Expert Review of Hematology
|
December 12, 2024
Clinical trials, challenges, and changes in TCR-based therapeutics for hematologic malignancies
Melinda A Biernacki, Marie Bleakley
Frontiers in Immunology
|
March 3, 2020
Neoantigens in Hematologic Malignancies
Melinda A Biernacki, Marie Bleakley
Cancer Journal (Sudbury, Mass.)
|
May 29, 2019
T-Cell Receptor-Based Immunotherapy for Hematologic Malignancies
Melinda A Biernacki, Michelle Brault, Marie Bleakley
JCI Insight
|
May 8, 2020
T cell optimization for graft-versus-leukemia responses
Melinda A Biernacki, Vipul S Sheth, Marie Bleakley
Journal of Proteome Research
|
April 9, 2008
A concentration-dependent analysis method for high density protein microarrays
Ovidiu Marina, Melinda A Biernacki, Vladimir Brusic, et al.
Current Opinion in Immunology
|
October 11, 2025
Optimizing post-transplantation cell therapies to enhance graft-versus-leukemia effects in hematological malignancies
Simone A Minnie, Melissa M Berrien-Elliott, Melody Smith, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Blood
|
April 13, 2023
Location, location, location
Melinda A Biernacki
Blood Advances
|
February 13, 2026
The TCXpress lane to T-cell receptor-engineered T cells
Melinda A Biernacki
Blood Advances
|
February 24, 2026
The TCXpress lane to T-cell receptor-engineered T cells
Melinda A Biernacki
Transplantation and Cellular Therapy
|
November 1, 2025
Capturing the Big Picture of HY Antigens and Transplantation Outcomes
Melinda A Biernacki
Expert Review of Hematology
|
December 12, 2024
Clinical trials, challenges, and changes in TCR-based therapeutics for hematologic malignancies
Melinda A Biernacki, Marie Bleakley
Frontiers in Immunology
|
March 3, 2020
Neoantigens in Hematologic Malignancies
Melinda A Biernacki, Marie Bleakley
Cancer Journal (Sudbury, Mass.)
|
May 29, 2019
T-Cell Receptor-Based Immunotherapy for Hematologic Malignancies
Melinda A Biernacki, Michelle Brault, Marie Bleakley
JCI Insight
|
May 8, 2020
T cell optimization for graft-versus-leukemia responses
Melinda A Biernacki, Vipul S Sheth, Marie Bleakley
Journal of Proteome Research
|
April 9, 2008
A concentration-dependent analysis method for high density protein microarrays
Ovidiu Marina, Melinda A Biernacki, Vladimir Brusic, et al.
Current Opinion in Immunology
|
October 11, 2025
Optimizing post-transplantation cell therapies to enhance graft-versus-leukemia effects in hematological malignancies
Simone A Minnie, Melissa M Berrien-Elliott, Melody Smith, et al.
Page
of 3